Peter Wirth
Chairman en SYROS PHARMACEUTICALS, INC. .
Fortuna: 6 M $ al 31/03/2024
Relaciones activas
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Marsha Fanucci | F | 70 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.
FORMA Therapeutics, Inc.
 FORMA Therapeutics, Inc. BiotechnologyHealth Technology FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA. | 13 años |
| Gerald Quirk | M | 56 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 16 años |
| Nancy Simonian | M | 63 | 12 años | |
| James N. Campbell | M | 76 | 11 años | |
| Ya jing Chen | M | 56 | 3 años | |
| Thomas Wiggans | M | 72 |
FORMA Therapeutics, Inc.
FORMA Therapeutics, Inc. BiotechnologyHealth Technology FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA. | 3 años |
| Conley Chee | M | 54 | 3 años | |
| Wayne Frederick | M | 52 |
FORMA Therapeutics, Inc.
FORMA Therapeutics, Inc. BiotechnologyHealth Technology FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA. | 3 años |
| Selwyn Vickers | M | 64 |
FORMA Therapeutics, Inc.
FORMA Therapeutics, Inc. BiotechnologyHealth Technology FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA. | 2 años |
| Peter Kolchinsky | M | 47 |
FORMA Therapeutics, Inc.
FORMA Therapeutics, Inc. BiotechnologyHealth Technology FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA. | 4 años |
| Richard Young | M | 70 | 13 años | |
| Ying Du | M | 59 | 10 años | |
| Arturo Molina | M | 65 |
FORMA Therapeutics, Inc.
FORMA Therapeutics, Inc. BiotechnologyHealth Technology FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA. | 1 años |
| Jeffrey Kindler | M | 68 | 11 años | |
| Raj Bhikhu Parekh | M | 63 | 9 años | |
| Srini Akkaraju Akkaraju | M | 56 | 7 años | |
| Lina Zhang | F | - | - | |
| Ulrich Christian Otte | M | - | 2 años | |
| Tim Tyson | M | 71 | 2 años | |
| F. Edmondson | M | 58 | 4 años | |
| Jeannette Potts | M | 62 | 5 años | |
| Karen Hunady | F | - | 2 años | |
| Andrew Oh | M | 53 | 2 años | |
| Michel Vounatsos | M | 62 | 1 años | |
| Scott Morrison | M | 66 | 3 años | |
| Lonnie Moulder | M | 66 | 5 años | |
| Deborah Dunsire | M | 61 | 3 años | |
| Richard Gaynor | M | 74 | 3 años | |
| Wing Yu Leung | F | 53 | 10 años | |
| Kai Xian Chen | M | 79 | 6 años | |
| Joshua Smiley | M | 54 | 2 años | |
| William Lis | M | 60 | 6 años | |
| Sol Barer | M | 76 | 11 años | |
| John D. Diekman | M | 81 | 7 años | |
| S. Gail Eckhardt | M | 66 | 4 años | |
| Mary Wadlinger | F | 64 | 10 años | |
| Daniel Mendelson | M | 60 | 6 años | |
| Peter Huang | M | - | 2 años | |
| Steve Benz | M | - | 2 años | |
| Irena Webster | F | - |
FORMA Therapeutics, Inc.
FORMA Therapeutics, Inc. BiotechnologyHealth Technology FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA. | - |
| Ifeyinwa Osunkwo | M | - | 2 años | |
| Arnold Lewis Oronsky | M | 83 | 11 años | |
| Jason Haas | M | 56 | 3 años | |
| Hong Bo Lu | M | 53 | 5 años | |
| Thomas Haagen | M | 58 | 2 años | |
| Kristin Stephens | F | 51 | - | |
| Todd Shegog | M | 59 | 5 años | |
| Paul M. DeLuca | M | - |
University of Wisconsin
| 53 años |
| William Liang | M | 53 | 6 años | |
| Jonathan Wang | M | 42 | 10 años | |
| James Yan | M | 60 | 4 años | |
| Ning Xu | M | 59 | 10 años | |
| Shawn Tomasello | F | 65 | 7 años | |
| David Roth | M | 61 | 9 años | |
| Sara Nayeem | M | 75 | 6 años | |
| Joseph Swedish | M | 72 | 6 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Sanj Patel | M | 54 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 19 años |
| Henri A. Termeer | M | 78 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 28 años |
| Tao Fu | M | 52 | 5 años | |
| Felix Baker | M | 55 | 15 años | |
| Frank Lee | M | 56 | 3 años | |
| Mark Goldberg | M | 69 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 18 años |
| George Michael Douglas | M | - |
University of Wisconsin
| 6 años |
| Christopher Viehbacher | M | 64 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Michael A. Foley | M | 62 | 9 años | |
| Kyle Kuvalanka | M | 56 | 2 años | |
| Marietta Wu | M | 56 | 4 años | |
| Lloyd J. Dickinson | M | 76 |
University of Wisconsin
| 8 años |
| Jorge Conde | M | 47 | 3 años | |
| Rafael Amado | M | 60 | - | |
| Paolo Augusto Paoletti | M | 73 | 6 años | |
| Stephen Frank Mahoney | M | 53 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 12 años |
| A. Betz | M | 77 |
University of Wisconsin
| 8 años |
| Mike Harris | M | - |
University of Wisconsin
| 5 años |
| Alicia Secor | F | 62 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 15 años |
| Michal Silverberg | F | 48 | 3 años | |
| Thomas W. Beetham | M | 55 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 10 años |
| Gloria Matthews | M | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 6 años |
| Eugene W. Gerner | M | 76 |
University of Wisconsin
| 5 años |
| Stéphane Bancel | M | 51 | 4 años | |
| Steve Hall | M | 69 | 11 años | |
| Albert R. Zimmerli | M | 72 |
University of Wisconsin
| 5 años |
| Jerome R. Baier | M | - |
University of Wisconsin
| 5 años |
| Steven J. Burakoff | M | 81 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Phillip Sharp | M | 79 | 10 años | |
| Vicki Sato | M | 75 | 6 años | |
| Tom Stevens | M | - |
University of Wisconsin
| 6 años |
| James R. Zuhlke | M | 77 |
University of Wisconsin
| 7 años |
| Cornelius McGillicuddy | M | 83 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Dave D. Halford | M | 77 |
University of Wisconsin
| 7 años |
| Amir Nashat | M | 51 | 8 años | |
| David P. Metzger | M | - |
University of Wisconsin
| 8 años |
| Tom Frisbie | M | 72 |
University of Wisconsin
| 6 años |
| Daniel L. Goelzer | M | - |
University of Wisconsin
| 8 años |
| Barrett L. Browning | M | - |
University of Wisconsin
| 8 años |
| Paula Ragan | M | 54 |
Lysosomal Therapeutics, Inc.
 Lysosomal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lysosomal Therapeutics, Inc. engages in the innovation, research, and development in the field of neurodegeneration. It focuses in lysosomal biology in developing novel small molecules for use in the treatment of neurodegenerative diseases. The company was founded by Dimitri Krainc, Joseph Mazzulli, Henri A. Termeer, Robert J. Carpenter, Peter Wirth, Edmund J. Sybertz, and Kees Cornelis Been in 2011 and is headquartered in Cambridge, MA.
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 7 años |
| Louis J. Arcudi | M | 63 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 5 años |
| Stephen S. Kolkhorst | M | - |
University of Wisconsin
| 6 años |
| Michael Wyzga | M | 69 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 13 años |
| Terry Hefty | M | - |
University of Wisconsin
| 5 años |
Estadísticas
| País | Relaciones | % del total |
|---|---|---|
| Estados Unidos | 79 | 79.00% |
| Islas Caimán | 21 | 21.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Peter Wirth
- Red Personal
